A Study of TCD601 in de Novo Renal Transplant Recipients

NCT05669001 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation

Interventions

BIOLOGICAL: TCD601
BIOLOGICAL: belatacept
DRUG: ATG
DRUG: TAC
DRUG: MPA
DRUG: Corticosteroids

Sponsor

ITB-Med LLC